Other international studies have described the prevalence of diabetes among HCV-positive (HCV+) patients between 7.4 and 43.2% [11,12], feasibly explained by the contribution to T2D development of various mechanisms, including direct viral effects, insulin resistance, proinflammatory cytokines, and other immune-mediated phenomena [13]. Here, INS is linked to type 2 diabetes mellitus.